LEXETTE
Peakhalobetasol propionate
NDATOPICALAEROSOL, FOAM
Approved
May 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Clinical Trials (1)
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Started Nov 2020
22 enrolled
Palmoplantar PsoriasisPlaque Psoriasis
Loss of Exclusivity
LOE Date
May 30, 2037
136 months away
Patent Expiry
May 30, 2037
Patent Records (3)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 10857159 | Nov 30, 2036 | Product | — |
| 11020407 | Nov 30, 2036 | Product | U-3143 |
| 10857159*PED | May 30, 2037 | — |